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Polycomb group (PcG) proteins are required for maintaining the silent state of the homeotic genes and other
important developmental regulators. The silencing function of the PcG proteins has been linked to their
intrinsic histone modifying enzymatic activities. The EED-EZH2 complex, containing the core subunits EZH2,
EED, SUZ12, and RbAp48, functions as a histone H3K27-specific methyltransferase. Here we describe the
identification and characterization of a related EED-EZH2 protein complex which is distinguished from the
previous complex by the presence of another PcG protein, hPHF1. Consistent with the ability of hPHF1 to
stimulate the enzymatic activity of the core EED-EZH2 complex in vitro, manipulation of mPcl1, the mouse
counterpart of hPHF1, in NIH 3T3 cells and cells of the mouse male germ cell line GC1spg results in global
alteration of H3K27me2 and H3K27me3 levels and Hox gene expression. Small interfering RNA-mediated
knockdown of mPcl1 affects association of the Eed-Ezh2 complex with certain Hox genes, such as HoxA10, as
well as Hox gene expression concomitant with an alteration on the H3K27me2 levels of the corresponding
promoters. Therefore, our results reveal hPHF1 as a component of a novel EED-EZH2 complex and demon-
strate its important role in H3K27 methylation and Hox gene silencing.
Polycomb group (PcG) and Trithorax group (TrxG) proteins
are key components required for the maintenance of long-term
repressive and active chromatin states, respectively (9). They
have been shown to play an important role in the regulation of
homeotic box (HOX) genes and other developmental and cell
cycle regulatory genes. Biochemical and genetic studies have
provided considerable evidence that PcG proteins function in
multiprotein complexes. At least two PcG protein complexes
with distinct biochemical properties have been characterized.
The 2-MDa Polycomb repressive complex 1 (PRC1) is com-
prised of the core subunits Polycomb (PC), Polyhomeotic
(PH), and the three ring domain-containing proteins RING1,
RING2, and BMI-1, which possess H2A-K119 ubiquitin E3
ligase activity (29). The catalytic subunit has been mapped to
RING2, while the presence of RING1 and BMI-1 can enhance
the enzymatic activity (1, 2, 14). Components from the tran-
scriptional machinery, including TBP (TATA-binding protein)
and TATA box-binding protein-associated factors (TAFs), are
also observed to associate with the PRC1 complex in Drosoph-
ila melanogaster (23), indicating that the interaction might pro-
vide a platform for PRC1 to function at promoters.
The EED-EZH2/PRC2 complex contains EZH2, SUZ12,
EED, and RbAp48 and has been demonstrated to have intrin-
sic histone methyltransferase (HMTase) activity toward
H3K27 (3, 6, 13, 18). Silencing of some Hox genes requires
coordinated action of the two PcG complexes. The prerequi-
site of H3K27 methylation mediated by the PRC2 complex for
the recruitment of the PRC1 complex, through the specific
recognition of H3K27me3 by the chromo domain of the PC
protein (8, 16), in some Hox genes provides evidence for the
molecular basis of the coordinated action of these two PcG
protein complexes (2). With regard to the PRC2 complex, the
SET domain-containing protein EZH2 is the catalytic subunit
responsible for H3K27 methylation. However, each of the
other components of the complex is indispensable for the over-
all function of the complex. For example, SUZ12 is required
for the minimum activity of the complex in vitro and genome-
wide H3K27 di- and trimethylation in vivo (4, 22). In contrast,
EED is required for all states of H3K27 methylation, including
monomethylation (17). RbAp48, the mammalian homolog of
Nurf55, has been reported to bind directly to helix 1 of histone
H4, which is usually inaccessible within the nucleosome (27).
In Drosophila, Nurf55 together with Su(z)12 is the minimal
nucleosome-binding module of the Esc-E(z) complex to an-
chor the complex on the chromatin substrates (20). The four
components have been demonstrated to be the functional core
of the PRC2 complex.
In Drosophila, an association between E(z) and another PcG
protein named Polycomblike (PCL) has been observed and
PCL shares the same polytene staining pattern with E(z) (21,
26). Indeed, a 1-MDa Esc-E(z) complex containing PCL and
the histone deacetylase RPD3 is present during early embryo-
genesis. The different composition of the Esc-E(z) complex
may be involved in the silencing of different targets. PCL con-
tains two plant homeodomain (PHD) domains, a motif present
in many proteins involved in chromatin function, such as
CHD3, Mi2, TRX, ASH1, and ASH2. It has recently been
shown that PHD domains link histone methylation to active
chromatin remodeling (24, 32). Multiple PCL homologs have
been identified in mammals. For example, there are three
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genes in the mouse genome that encode PCL homologs,
namely mPcl1, mPcl2, and mPcl3.
Here we report the identification and functional character-
ization of a novel EED-EZH2 complex, which is distinguished
from the previously characterized PRC2 complex by the pres-
ence of hPHF1, the closest human homolog of Drosophila
PCL. By comparing the enzymatic activities of different EED-
EZH2 complexes in the presence or absence of hPHF1, we
show that hPHF1 positively regulates the H3K27 methyltrans-
ferase activity of the EED-EZH2 core complex in vitro. In
addition, we demonstrate that the mouse homolog of hPHF1 is
important for H3K27 methylation and Hox gene expression in
vivo. Finally, chromatin immunoprecipitation (ChIP) assays
demonstrate that mPcl1 directly contributes to HoxA10 silenc-
ing by facilitating the recruitment of the Eed-Ezh2 complex
and subsequent H3K27 methylation at its promoter. There-
fore, our study not only provides strong evidence that hPHF1
is an integral component of a novel EED-EZH2 complex, but
also demonstrates its important function in H3K27 methyl-
ation and Hox gene silencing.
MATERIALS AND METHODS
Purification and identification of an hPHF1-containing EED-EZH2 complex.
HeLa nuclear proteins were separated into nuclear extract and nuclear pellet
fractions as previously described (28). After solubilization, proteins derived from
nuclear pellets were resuspended in buffer D (50 mM Tris-HCl [pH 7.9], 0.1 mM
EDTA, 2 mM dithiothreitol [DTT], 0.2 mM phenylmethylsulfonyl fluoride
[PMSF], and 25% glycerol) containing 20 mM ammonium sulfate (BD20) and
loaded onto a DEAE52 column equilibrated with BD20. Proteins bound to
DEAE52 column were step eluted with BD350 and BD500. The BD350 fraction
was dialyzed against buffer C (50 mM Tris-HCl [pH 7.9], 0.2 mM EDTA, 1 mM
DTT, 0.2 mM PMSF, and 20% glycerol) containing 100 mM potassium chloride
(BC100) and loaded onto a phosphocellulose P11 column. The column was step
eluted with BC300, BC500, and BC1000. The BC500 fraction was then dialyzed
against BD20 and subjected to a DEAE-5PW column (TosoHaas). The bound
proteins were eluted with a 10-column-volumn (cv) linear gradient from BD20 to
BD500. HMTase activities were separated into two peaks on this column. The
first peak fractions were pooled and adjusted to BD500 using saturated ammo-
nium sulfate and were then loaded onto a phenyl-Sepharose column (Pharma-
cia). The bound proteins were eluted with a 15-cv linear gradient from BD500 to
BD0. HMTase activities were again split into two peaks. The fractions from both
peaks were pooled separately and further fractionated following the same
scheme described below. The pooled fractions were dialyzed into BC50 and then
subjected to a Sephacryl S300 gel filtration column (Pharmacia). The HMTase
activities eluted with a relative molecular mass of between 670 and 443 kDa from
both pools. The fractions containing the HMTase activities were pooled, dialyzed
against buffer P (5 mM HEPES-KOH [pH 7.5], 0.2 mM EDTA, 40 mM KCl,
0.01% Triton X-100, 0.01 mM CaCl2, 1 mM DTT, 0.05 mM PMSF, and 10%
glycerol) containing 10 mM potassium phosphate (BP10), and loaded onto a
hydroxyapatite column. The bound proteins were eluted with a 12-cv linear
gradient from BP10 to BP600. Fractions containing HMTase activity were com-
bined and dialyzed into buffer BC150. The bound proteins were then eluted with
a 10-cv linear gradient from BC150 to BC500. Finally, the active fractions were
subjected to an affinity column containing protein A beads coated with SUZ12
antibodies to purify the EED-EZH2 complex. For protein identification, the
candidate polypeptides were digested with trypsin and identified as previously
described (28).
Purification of recombinant hPHF1-containing EED-EZH2 complex. hPHF1
cDNA was PCR amplified from an I.M.A.G.E cDNA clone, and the sequence
was verified by DNA sequencing. The baculovirus construct was generated by
insertion of the open reading frame of hPHF1 into the pFASTBAC vector
(GIBCO) between the EcoRI and XhoI sites. The virus was generated and
amplified according to the manufacturer’s protocol. The baculoviruses for other
components of the EED-EZH2 complex were previously described (4). The
procedure for purification of the EED-EZH2 complex with or without hPHF1
was also described previously (4). The eluted complexes from the Flag affinity
column were further purified over a gel-filtration Superose 6 column (Phar-
macia).
HMTase assay and substrate preparations. Oligonucleosome, mononucleo-
some, and core histone substrates used for HMTase assays were purified from
HeLa cells as described previously (4). Wild-type and mutant recombinant his-
tone H3 were generated and purified as described previously (4). HMTase assays
were performed essentially as previously described (28).
Kinetic analysis of the HMTase assay. The histone methylation assay was
performed with a series of reactions containing increasing concentrations of
3H-labeled S-adenosylmethionine (3H-SAM). The reactions were allowed to
proceed for 15 min and then stopped by addition of sodium dodecyl sulfate
(SDS) loading buffer. Histones were separated by SDS-polyacrylamide gel elec-
trophoresis (PAGE). Gels were exposed to film, and histone methylation was
quantified by scintillation counting of bands containing histone 3 (H3) excised
from gels. A histone sample with a known amount of radioactivity (cpm) was run
at the same time to calibrate the incorporated methyl groups.
Plasmids and antibodies. Full-length hPHF1 cDNA was cloned into EcoRI
and XhoI sites of pGEX-KG vector for the production of glutathione S-trans-
ferase (GST)-fusion protein. Antibodies against hPHF1 were generated in rabbit
using hPHF1(230–567) as an antigen. Antibodies against SUZ12, H3K27me1,
H3K27me2, H3K27me3, H3K4me2, and H3K9me3 have been previously de-
scribed (4).
Generation and analysis of stable mPcl1 knockdown and Flag-mPcl1-rescued
cell lines. 3T3 and GC1spg cells were cultured in Dulbecco’s modified Eagle’s
medium supplemented with 10% fetal bovine serum at 37°C. The lentiviral
vector pTY was requested from NIH AIDS Research & Reference Reagent
Program and was modified by replacing LacZ with an internal ribosome entry
site followed by either puromycin or enhanced green fluorescent protein (eGFP)
for selection. The pTY-U6-mPcl1 small interfering RNA (siRNA) vector was
cotransfected with pHP, pVSVG, and pCEP4tat into 293T cells with Superfect
(Qiagen). The supernatant containing lentivirus was collected 36 h posttransfec-
tion and transduced into NIH 3T3 or GC1spg cells with 8 g/ml Polybrene
(Sigma). Stably transfected cells were selected in the presence of 2 g/ml puro-
mycin. To generate rescued cell lines, the stable KD cells were further trans-
duced with lentiviruses expressing eGFP and Flag-mPcl1, which contains muta-
tions on the siRNA targeting sequence. eGFP-positive cells were sorted by
fluorescence-activated cell sorting and expanded for further analysis. RNAs were
extracted from the above cell lines and analyzed by reverse transcription-PCR
(RT-PCR) and real-time qPCR. The primer sequences for the Hox gene analysis
were described previously (2). The oligonucleotides used to target mPcl1
mRNAs are RNA interference 1 (RNAi-1) sense primer GATGTGCTGGCCA
GATGGA and antisense primer TCCATCTGGCGAGCACATC and RNAi-2
sense primer GGTCACCTCTGGGACTTCA and antisense primer TGAATG
CCCAGAGGTGACC. The oligonucleotides used to target mEzh2 mRNAs are
RNAi-1 sense primer GTATGTGGGCATCGAACGA and antisense primer
TCGTTCGATGCCCACATAC. The primers used in the quantitative PCR
(qPCR) were mPcl1 cDNA primers TGTTGTGTGTGTCGCTCTGA and AA
ATGTCCAGCATCCCAGTC and mEzh2 cDNA primers AACCCTGTGACC
ATCCACGGC and ATCAGACGGTGCCAGCAGTAAG. ChIP assays were
performed with indicated antibodies as previously described (4). The primer
pairs across the mouse Hox A10 genomic locus were designed by Array designer
(Premierbiosoft) and listed as follows: 1, AAGTGTGTGAGCGAAAATTGTG
and TCCAGCATTAACACAGTTTCAG; 2, TCTCCCAGGGATGGTGAA
TCTC and ACTTGCTACCAGCCTCACAGAC; 3, AGTAGAGGCAGCCGT
TGTAGTG and TCCTGAGCCGTCCCTGTCTG; 4, GCATAGCCTCCTGGG
TGTGG and AGGCTGAGCTGGGTTTGGG; 5, AAATGGCTGGGAAAAG
GACTGC and GCCGATGATCAATGCCTGGATC; 6, TGGCCTCGACTTA
ACCTTCC and AACAAACACCAAGCAAACAGAC; 7, TCAGTGTCAAGT
CCTGAATGGG and GAAGGATTTTAGCCAGGCAAGC; and 8, TCCATT
TTATCCTGTCCACCAC and GTGGCCTAGCGGAGGACC. Platinum Taq
polymerase (Invitrogen) and Sybr green master mix (Applied Bioscience) were
used for PCR and real-time qPCR, respectively.
RESULTS
Purification and identification of an hPHF1-containing
EED-EZH2 complex in HeLa cells. By monitoring HMTase
activity, we previously purified and characterized an H3K27-
specific methyltransferase EED-EZH2 complex (3). In the
same purification, we noticed that the nucleosomal histone
H3-specific methyltransferase activity split into two peaks on
the DEAE-5PW column (Fig. 1B). From peak 2, we purified
and characterized the EED-EZH2 complex, which contains
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EZH2, EED, SUZ12, RbAp48, and AEBP2 (3). To identify
and characterize the enzymatic activity in peak 1, the proteins
were fractionated on a phenyl Sepharose column, which fur-
ther split the enzymatic activity into two peaks (Fig. 1C, top
panel). Western blot analysis of the column fractions indicated
that EZH2, SUZ12, RbAp48, and RbAp46 all cofractionate
with the two enzymatic activities (Fig. 1C, bottom three pan-
els). To define the composition of the two enzymatic activities,
FIG. 1. Purification and identification of hPHF1-containing EED-EZH2 complex. (A) Scheme used for purification of EED-EZH2 complexes.
Numbers indicate the salt concentration (mM) at which the HMTase activity elutes from the respective columns. Nucleosomes were used as
substrate in all of the HMTase assays. (B) HMTase activity assay of the fractions derived from the DEAE-5PW column. -, anti-. (C) HMTase
activity assay (top panel) and Western blot analysis (bottom panels) of fractions derived from the phenyl-Sepharose column. The antibodies used
for Western blot analysis are indicated on the left side of the panel. (D) Silver staining of immunoprecipitated samples using antibodies against
SUZ12. The positions of the protein size markers are indicated to the left of the panel. In, Ft, and IP represent input, flowthrough, and
immunoprecipitates, respectively. The polypeptides copurified were identified by mass spectrometry, and their identities are indicated on the right.
Representative peptides identified from mass spectrometry covering 41% of hPFH1 (GenBank accession no. BC008834) are shown in the box.
(E) Phylogenetic tree of hPHF1 homologs from humans, mice, and flies. The relative positions of the conserved tudor domain and PHD domains
are indicated. Numbers of amino acids for each protein are indicated.
FIG. 2. Characterization of the hPHF1-containing EED-EZH2 complex in vitro. (A) Scheme for the steps carried out to reconstitute
hPHF1-containing EED-EZH2 complex. a-Flag, anti-Flag. (B) Silver staining (top panel) and Western blotting (bottom panels) of the fractions
derived from the Superose 6 gel-filtration column. The elution profile of the protein standards is indicated on top of the panel. The protein size
markers are indicated to the left of the top panel. The antibodies (-, anti-) used for Western blotting are indicated on the right. The six
components of the reconstituted complex are indicated with asterisks. hPHF1 is stained weakly by silver. (C) Coomassie staining of a polyacryl-
amide-SDS gel containing the EED-EZH2 complexes in the presence or absence of hPHF1. Contaminating proteins from insect cells are indicated
by asterisks. (D) Comparison of the substrate specificities of the two different recombinant EED-EZH2 complexes. Equal amounts of histone H3
alone or in octamer or mono- or oligonucleosome forms (bottom panel) were used as substrates for methylation by the two complexes shown in
panel C (top two panels). (E) Time course experiment comparing the HMTase activities of the two complexes shown in panel C. A quantification
of the top panel by scintillation counting is shown in the bottom panel.
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the samples were further fractionated sequentially on S300,
hydroxyapatite, and MonoQ columns before being affinity pu-
rified using an anti-SUZ12 antibody column (Fig. 1A). Silver
staining followed by mass spectrometry analysis of the affinity
purified samples indicated that both enzymatic protein com-
plexes contain EZH2, SUZ12, EED, RbAp48, and RbAp46.
However, hPHF1 was only present in complex 1 (Fig. 1D).
Sequence analysis indicated that hPHF1 is highly related to
the Drosophila PcG protein PCL. The fly Pcl gene was identi-
fied in a genetic screen as an enhancer of Polycomb (Pc), and
both homozygous and heterozygous mutants exhibit lethal and
homeotic phenotypes (7). Previous studies have demonstrated
that the Drosophila PCL protein associates with the ESC-E(Z)
complex during early embryogenesis and can directly interact
with E(Z) through its PHD fingers (21, 26). In contrast to
Drosophila, where only a single Pcl gene exists, three genes that
code for protein homologs to fly Pcl have been identified in
both human and mouse genomes (Fig. 1E). hPHF1 was
mapped to chromosome 6p21.3 by fluorescence in situ hybrid-
ization and shows 42% similarity to Drosophila Pcl (5). Its
closest mouse homolog, mPcl1, originally named Tctex3 (T-
complex testis expressed 3), is expressed specifically in the
testis (12), but its function remains unknown. mPcl2 was ini-
tially cloned as a metal response transcription factor, Mtf2/
M96 (11). Loss of functional mutation in mice causes posterior
transformation of axial skeletons with low penetrance that is
less severe than the defects exhibited with Pcl mutation in
Drosophila, indicating that there might be functional redun-
dancy among the Pcl homologs in mice (30). hPCL3 was first
identified in humans and has been shown to be upregulated in
multiple cancers (31). The function and expression pattern of
mPcl3 remain to be characterized.
hPHF1 stimulates the enzymatic activity of the EED-EZH2
complex by affecting the reaction Vmax and Km. To assess the
potential role of hPHF1 in modulating the enzymatic activity
of EED-EZH2 complex, we reconstituted the EED-EZH2
complex in the presence or absence of hPHF1 following the
scheme outlined in Fig. 2A. A homogenous EED-EZH2 com-
plex with hPHF1 was purified by affinity chromatography fol-
lowed by gel filtration to remove unincorporated free Flag-
EED and Flag-EED-containing subcomplexes (Fig. 2B). Silver
staining and Western blot analysis of the column fractions
confirmed that hPHF1 copurifies with other components in a
protein complex between 440 and 670 kDa, which behaves
FIG. 3. Kinetic analysis of the EED-EZH2 complex in the presence or absence of hPHF1. Representative autoradiographs of HMTase assays
containing different concentrations of 3H-SAM are shown in the top panels. Lineweaver-Burk plots (or double-reciprocal plots) of the reactions
are shown in the middle panels. Vmax and Km were determined and are indicated on the plots. Michaelis-Menten plots were generated and are
shown in the bottom panels. EED-EZH2 complex in the absence or presence of hPHF1 was used as the enzyme in panels A and B, respectively.
1866 CAO ET AL. MOL. CELL. BIOL.
similarly to the native complex (Fig. 1A). Using the same
strategy, we also reconstituted and purified a complex without
hPHF1 (Fig. 2C). We note that hPHF1 is not stained well by
silver (Fig. 2B) but is readily detected by Coomassie staining
(Fig. 2C).
Previous studies indicated that the EED-EZH2 complex
prefers oligonucleosome substrates (4). To test whether incor-
poration of hPHF1 in the EED-EZH2 complex affects its sub-
strate preference, equal amounts of histone H3 in various
forms were subjected to methylation by equal amounts of
EED-EZH2 complex in the presence or absence of hPHF1.
The results shown in Fig. 2D indicate that incorporation of
hPHF1 might increase its relative activity for oligonucleosome
substrates. In addition, a time course experiment demon-
strated that incorporation of hPHF1 into the complex im-
proved the kinetics of the methylation reaction (Fig. 2E). How-
ever, incorporation of hPHF1 does not change the site
specificity (H3K27) of the EED-EZH2 complex (data not
shown).
To understand the exact effect of hPHF1 on the reaction
kinetics, we performed methyltransferase reactions using a
wide range of SAM concentrations and allowed the reaction to
proceed for only 15 min to keep it in the linear range (Fig. 3).
The maximal velocity (Vmax) and the Michaelis-Menten con-
stant (Km) were then derived from the Lineweaver-Burk plot
(or double-reciprocal plot) (Fig. 3, middle panels). Based on
the calculated Vmax and Km, accurate Michaelis-Menten plots
were generated. This analysis revealed that incorporation of
hPHF1 increased the reaction Vmax from 70 to 189 methyl
histones/min/enzyme, while it decreased the Km from 0.88 to
0.60 M. Together, these data allow us to conclude that
hPHF1 stimulates the activity of EED-EZH2 complex by in-
creasing the Vmax 2.7-fold and decreasing the Km 1.5-fold.
Knockdown of mPcl1 affects Hox gene expression. To assess
the function of hPHF1 in H3K27 methylation in vivo, we used
a lentivirus-derived siRNA approach in NIH 3T3 cells to gen-
erate two stable knockdown cell lines, KD1 and KD2, which
target the N-terminal or C-terminal region of mPcl1, respec-
tively. Semiquantitative and real-time RT-PCR analysis dem-
onstrated over 60 to 70% reduction in the mRNA levels of the
two knockdown cell lines (Fig. 4A). Because mPcl1 only pre-
sents in a subpopulation of the Eed-Ezh2 complexes, we also
generated a stable Ezh2 knockdown cell line using a similar
strategy for purposes of comparison. Characterization of the
Ezh2 knockdown cell line by semiquantitative and real-time
RT-PCR indicates that about 70% knockdown at the mRNA
level was achieved (Fig. 4B). To evaluate the respective effects
of mPcl1 and Ezh2 knockdown on Hox gene expression, we
analyzed the expression levels of all 39 mouse Hox genes in the
knockdown cells and compared them to that in the control cells
by RT-PCR. Due to the low expression levels of some Hox
genes in NIH 3T3 cells, we were able to detect expression of
only 18 Hox genes. Results shown in Fig. 4C indicate that Ezh2
knockdown resulted in a broad and significant change in Hox
gene expression. In contrast, knockdown of mPcl1 only af-
fected expression of a limited number of genes. Interestingly,
most genes that are affected by mPcl1 knockdown are down-
regulated, but HoxA10 is up-regulated in response to Ezh2 and
FIG. 4. Knockdown of mPcl1 and Ezh2 in NIH 3T3 cells affects Hox gene expression. (A) Characterization of the stable mPcl1 knockdown cell
lines by RT-PCR (left panel) and RT-qPCR (right panel). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as control (Ctrl) in
both experiments. (B) Characterization of a stable Ezh2 knockdown cell lines by RT-PCR (left panel) and RT-qPCR (right panel). GAPDH was
used as a control. (C) RT-PCR analysis of Hox gene expression pattern in response to knockdown of mPcl1 (lanes 2 and 3) or Ezh2 (lane 5).
GAPDH serves as a control for equal input. The Hox genes affected by knockdown of mPcl1 or Ezh2 are underlined.
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mPcl1 knockdown. Given that PcG proteins are known to be
involved in transcriptional silencing, genes that are down-reg-
ulated by Ezh2 or mPcl1 knockdown might be a result of
indirect effects.
Because very few Hox genes analyzed are affected by mPcl1
knockdown in NIH 3T3 cells, it is possible that NIH 3T3 is not
the appropriate cell type for analysis of mPcl1 function. Since
mPcl1 (also named Tctex3) was first identified due to its
unique and restricted expression pattern in male germ cells
(12), we speculated that knockdown of mPcl1 in male germ
cells might cause a broader effect on Hox gene expression.
Therefore, we generated knockdown of mPcl1 in GC1Spg
cells, an immortalized mouse male germ cell line that consti-
tutively expresses the simian virus 40 large T antigen (15),
FIG. 5. Knockdown of mPcl1 in GC1Spg cells affects Hox gene expression. (A) Characterization of the stable mPcl1 knockdown cell lines by
RT-PCR (left panel) and RT-qPCR (right panel). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a control (Ctrl) in both
experiments. (B) RT-PCR analysis of Hox gene expression pattern in response to knockdown of mPcl1 relative to control. GAPDH serves as a
control for equal input. The Hox genes whose expression is affected by mPcl1 knockdown are underlined. (C) RT-qPCR analysis of selected genes
affected by mPcl1 knockdown shown in panel B. Results are normalized to GAPDH and are presented as means  standard deviations from two
independent experiments.
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using the KD2 lentivirus-delivered siRNA. Expectedly, more
efficient knockdown was achieved in this cell line, with a more
than 80% reduction in the mRNA level as determined by
real-time PCR (Fig. 5A). Interestingly, the expression levels of
multiple Hox genes were altered and most of them, including
HoxA10, are upregulated by knockdown of mPcl1 (Fig. 5B and
C). Because a higher knockdown efficiency for mPcl1 and a
broader effect on Hox gene expression are observed in the
GC1spg cell line, we performed further analysis of mPcl1 func-
tion in this cell line. Because mPcl1 knockdown resulted in
significant up-regulation of the HoxA10 gene in two different
cell lines, subsequent analysis was focused on this gene.
Pcl1 contributes to H3K27me2 and H3K27me3 level in vivo.
To exclude possible off-target effects of mPcl1 knockdown
and to overcome the problem that no Pcl1 antibody capable
of working for ChIP is available, we generated a cell line
that stably expresses Flag-mPcl1 using the GC1spg-derived
Pcl1 knockdown cell line (Fig. 6A). RT-PCR analysis indi-
cated that the expression of Flag-mPcl1 restored the mPcl1
level to that of the control (Fig. 6B, middle panel). Impor-
tantly, rescue of mPcl1 knockdown resulted in recovery of
HoxA10 silencing (Fig. 6B, top panel), demonstrating that
mPcl1 plays an important role in HoxA10 silencing. To
address whether mPcl1 knockdown affects the global H3K27
methylation level, we compared the H3K27 methylation lev-
els of histones isolated from control, knockdown, and res-
cued cell lines. Results shown in Fig. 6C indicate that mPcl1
knockdown results in a global decrease in H3K27me2 and
H3K27me3 levels but has no obvious effects on the levels of
other modifications, such as H3K27me1, H3K4me2, or
H3K9me3 (Fig. 6C, lanes 1 and 2). Quantification of the
methylation levels indicates that knockdown of mPcl1 re-
sulted in decreases of genome-wide H3K27 di- and trimeth-
ylation levels to 30% and 70% of the control levels, respec-
tively (Fig. 6D). Apparently this effect is directly related to mPcl1
knockdown, as rescue of mPcl1 expression by Flag-mPcl1 re-
stored the H3K27 methylation levels (Fig. 6C and D).
Binding of mPcl1 to HoxA10 correlates to increased
H3K27me2 level and HoxA10 silencing. To further character-
ize the relationship between mPcl1 binding, H3K27 methyl-
ation and HoxA10 silencing, we performed ChIP analysis
across the entire HoxA10 gene using control, mPcl1 knock-
FIG. 6. HoxA10 is a direct target of mPcl1. (A) Characterization of a stable Flag-mPcl1-rescued cell line by Western blotting. Equal loading
was confirmed by Western blotting using -tubulin antibody. -Flag, anti-Flag antibody; Ctrl, control. (B) RT-PCR analysis of HoxA10 and mPcl1
expression in mock, mPcl1 knockdown, and Flag-mPcl1-rescued cell lines. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) served as a
control for equal input. (C) Western blot analysis of histone extracts from control, knockdown, and Flag-mPcl1-rescued cell lines. The antibodies
used are indicated. Equal loading was verified by antibody against histone H3 (top panel). (D). Quantitative analysis of the changes of mono-, di-,
and trimethylation shown in panel C by Licor image software. The data were normalized with total histone H3 and are presented as relative
intensity from three independent experiments.
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down, and Flag-mPcl1-rescued cells. Antibodies used for ChIP
assays include anti-Suz12, anti-Flag, and all three forms of
anti-H3K27me. An equal amount of IgG was used as a control
for antibody specificity. Results shown in Fig. 7B indicate that
Flag-mPcl1 is localized to the promoter and upstream flanking
region (amplicons 3 to 5; bottom panel). H3K27me2 and
H3K27me3 levels are also enriched in the same region in the
Flag-mPcl-rescued cells compared to that in the knockdown
cells. However, H3K27me1 signal was not detected in all re-
gions examined. Interestingly, knockdown of mPcl1 resulted in
a significant decrease in H3K27me2 levels, while only a mild
decrease in H3K27me3 levels is observed (Fig. 7B, compare
left and middle panels). Notably, in region 4 and the surround-
ing region, H3K27 dimethylation and trimethylation were de-
creased to less than 40% and 70%, respectively (Fig. 7C).
Importantly, the decreased H3K27 methylation caused by
mPcl1 knockdown was restored to the control level in the
rescued cells (Fig. 7B and C). Moreover, knockdown of mPcl1
appears to cause a subtle, but consistent, decrease in binding of
Suz12 to the promoter region (Fig. 7B, amplicons 4 and 5, and
C), which is also restored in the rescue cells (Fig. 7B, ampli-
cons 4 and 5, and C). mPcl1 binding appears to correlate with
Suz12 recruitment and H3K27 methylation. This raises the
possibility that mPcl1 may contribute to Eed-Ezh2 recruitment
to a subset of Hox genes. This possibility is consistent with a
previous study demonstrating a direct interaction between the
PHD domains of Drosophila PCL and E(Z) (21).
DISCUSSION
Drosophila PCL was initially identified in a yeast two-hybrid
screen as an interaction partner of E(Z) (21). This interaction
was later confirmed by the isolation of a 1-MDa protein com-
plex from Drosophila embryo extracts that contains all of the
core components of the ESC-E(Z) complex, as well as PCL
and RPD3, a histone deacetylase (26). In this study, we provide
evidence that one of the human homologs of PCL, hPHF1
associates with the core components of the EED-EZH2 com-
plex and has the capacity to modulate its enzymatic activity and
Hox gene expression. By comparing the enzymatic activity of a
native Drosophila PCL-containing complex and a reconstituted
ESC-E(Z) complex, another group recently suggested that
PCL might enhance the enzymatic activity of the ESC-E(Z)
complex (19). Given that the study failed to reconstitute a
PCL-containing complex, it cannot rule out the possibility that
the observed difference in enzymatic activities is caused by
FIG. 7. mPcl1 knockdown leads to a decreased H3K27me2 level at the promoter region, which can be rescued by expression of Flag-mPcl1.
(A) Diagram of the HoxA10 gene in which the two exons are indicated by boxes labeled with 1 and 2. The regions analyzed are indicated with bars
and are labeled from 1 to 8. Each region covers about 500 bp. (B) ChIP analysis of the HoxA10 gene using various antibodies (-, anti-) indicated
on the right. The cell lines used in ChIP are indicated at the bottom of each panel. The different amplicons analyzed are indicated on top of the
panel. Ctrl, control. (C). ChIP-qPCR analysis of the relative levels of mono-, di-, and trimethylation of H3K27, Suz12, and Flag-mPcl1 on region
4 shown in panel A. Results are shown as percentages of enrichment relative to input. The data shown represent means  standard deviations from
two independent experiments.
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differences in the native and reconstituted complexes other
than PCL. In contrast, by comparing the reconstituted com-
plexes in the presence or absence of hPHF1 directly, we re-
vealed a potential role for hPHF1 in modulating the enzymatic
activity of the EED-EZH2 complex.
To understand the molecular mechanism by which hPHF1/
mPcl1 affects H3K27 methylation and Hox gene silencing, we
put significant effort into characterizing the conserved PHD
and tudor domains that are present in the hPHF1 protein.
Given that both PHD and tudor domains have been recently
demonstrated to have the capacity of binding to methylated
histones (10, 24, 32), we explored the possibility that hPHF1
may bind to a specifically methylated histone lysine residue by
a variety of approaches. These attempts failed to generate any
convincing data supporting recognition of any methylated ly-
sine residues on histones by hPHF1 (data not shown). Further-
more, deletion of the second PHD domain, which contains the
most conserved aromatic residues predicted to be potential
methyl-lysine recognition sites, does not affect the ability of
Flag-mPcl1 to rescue the altered Hox gene expression in re-
sponse to mPcl1 knockdown (data not shown). These results
do not support that recognition of methylated histone lysine
residues is the underlying mechanism for hPHF1 to stimulate
the EED-EZH2 methyltransferase activity and Hox gene si-
lencing. However, hPHF1 does appear to recognize a specific
feature of nucleosomes, as it can interact with nucleosomes in
vitro (data not shown). This property, in combination with the
fact that PCL interacts directly with E(Z) (21), may explain
why hPHF1 can stimulate the enzymatic activity of the EED-
EZH2 complex.
In Drosophila, homozygous Pcl mutant embryos exhibit vari-
able short-range transformation toward the posterior, while
the anterior segments remain unaffected. This phenotype is
different from those exhibited by other PcG mutants such as
those with mutation of Pc or Esc, suggesting that they each may
have some unique functions (7, 25). Consistent with this ob-
servation, removal of PCL in embryos or in imaginal discs only
decreased, but did not abolish, H3K27 trimethylation, which is
different from inactivation of E(Z). Moreover, Pcl mutants
also exhibit increased H3K27me1 and H3K27me2 levels con-
comitant with a decrease in H3K27me3 levels and Su(z)12
recruitment, suggesting that PCL might be only required for
generating the H3K27me3 mark at its target genes. However,
it is not clear how PCL achieves this effect (19). Several pieces
of evidence suggest that PCL and its homologs may have some
tissue-specific functions. For example, analysis of maternal and
zygotic Pcl mutants indicated that while only moderate misex-
pression of Hox genes was observed in the epidermis, much
broader and stronger misexpression of Hox genes was ob-
served in the viscera mesoderm and central nervous system
(25). Similarly, analysis of a PCL homolog in Xenopus also
revealed specific function in neuronal development (33). This
suggests that unlike the core components of the ESC-E(Z)
complex, which strongly repress Hox gene expression in all
tissues, PCL only regulates a subset of Hox genes in a tissue-
specific manner. Consistent with this notion, our analysis in
NIH 3T3 cells revealed that knockdown of mPcl1 affects ex-
pression of only a few Hox genes, while knockdown of Ezh2
alters expression of many Hox genes. However, when similar
experiments are performed in a mouse germ cell line, mPcl1
knockdown exhibits a much broader effect. Therefore, PCL
and its mammalian homologs might be important in defining
tissue-specific function of the EED-EZH2 complex. Future
work should be able to determine whether this is indeed the
case.
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